Medigen Vaccine Biologics Corporation (TPEX:6547)
Taiwan · Delayed Price · Currency is TWD 60.70
+0.20 (0.33%)
Sep 17, 2026, 1:30 PM CST
Medigen Vaccine Biologics Market Cap
Medigen Vaccine Biologics has a market cap or net worth of 19.89 billion as of September 17, 2026. Its market cap has increased by 59.21% in one year.
Market Cap
19.89B
Enterprise Value
18.95B
Revenue
573.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
60.70
ChartMarket Cap Chart
Since August 6, 2015, Medigen Vaccine Biologics's market cap has increased from 2.83B to 19.89B, an increase of 601.56%. That is a compound annual growth rate of 19.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 19.89B | 60.26% |
| Dec 31, 2025 | 12.41B | 4.72% |
| Dec 31, 2024 | 11.85B | -48.55% |
| Dec 29, 2023 | 23.04B | 1.10% |
| Dec 30, 2022 | 22.78B | -64.20% |
| Dec 30, 2021 | 63.65B | 192.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sunmax Biotechnology | 21.79B |
| Oneness Biotech | 21.05B |
| CHO Pharma | 18.16B |
| TaiMed Biologics | 16.36B |
| Ever Supreme Bio Technology | 15.51B |
| Gongwin Biopharm Holdings | 15.20B |
| EirGenix | 14.35B |
| Lumosa Therapeutics | 12.70B |